Litcius/Paper detail

DYRK1A inhibitors for disease therapy: Current status and perspectives

Tong Liu, Yuxi Wang, Jiaxing Wang, Changyu Ren, Hao Chen, Jifa Zhang

2021European Journal of Medicinal Chemistry106 citationsDOIOpen Access PDF

Topics & Concepts

DYRK1ANeurodegenerationHyperphosphorylationKinaseChemistryPathogenesisDiseaseCancer researchBiologyBiochemistryMedicineImmunologyInternal medicineSignaling Pathways in DiseaseUbiquitin and proteasome pathwaysPeptidase Inhibition and Analysis
DYRK1A inhibitors for disease therapy: Current status and perspectives | Litcius